Off-Label Use of Tenecteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis

IMPORTANCE: Tenecteplase is being evaluated as an alternative thrombolytic agent for the treatment of acute ischemic stroke (AIS) within ongoing randomized clinical trials (RCTs). In addition, nonrandomized clinical experiences with off-label use of tenecteplase vs alteplase for AIS treatment are be...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsanos, Aristeidis H., Psychogios, Klearchos, Turc, Guillaume, Sacco, Simona, de Sousa, Diana Aguiar, De Marchis, Gian Marco, Palaiodimou, Lina, Filippou, Dimitrios K., Ahmed, Niaz, Sarraj, Amrou, Menon, Bijoy K., Tsivgoulis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972028/
https://www.ncbi.nlm.nih.gov/pubmed/35357458
http://dx.doi.org/10.1001/jamanetworkopen.2022.4506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972028/
https://www.ncbi.nlm.nih.gov/pubmed/35357458
http://dx.doi.org/10.1001/jamanetworkopen.2022.4506

Ejemplares similares